2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Drug Testing and Analysis DRUG TEST ANAL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.2
50人评分
我要评分
声誉 7.4 影响力 5.0 速度 7.0 | |||||||||||||||||||||||||||||||||||||||||
期刊ISSN | 1942-7603 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||||||||||||
E-ISSN | 1942-7611 | |||||||||||||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 2.6 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年3月26日:2.445 | |||||||||||||||||||||||||||||||||||||||||
2023-2024自引率 | 26.90%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||||||||||
五年影响因子 | 2.4 | |||||||||||||||||||||||||||||||||||||||||
JCI期刊引文指标 | 0.76 | |||||||||||||||||||||||||||||||||||||||||
h-index | 44 | |||||||||||||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||||||||||||
期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611 | |||||||||||||||||||||||||||||||||||||||||
期刊投稿网址 | http://mc.manuscriptcentral.com/dta | |||||||||||||||||||||||||||||||||||||||||
期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Drug Testing and Analysis的语言要求,还能让Drug Testing and Analysis编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Drug Testing and Analysis编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||||||||||||
通讯方式 | JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ | |||||||||||||||||||||||||||||||||||||||||
出版商 | John Wiley and Sons Ltd | |||||||||||||||||||||||||||||||||||||||||
涉及的研究方向 | BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL | |||||||||||||||||||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||||||||||||||||||||||
出版年份 | 2009 | |||||||||||||||||||||||||||||||||||||||||
年文章数 | 166点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||||||||||
Gold OA文章占比 | 35.42% | |||||||||||||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 95.18% | |||||||||||||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:2区
| |||||||||||||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1942-7603%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均3.0个月 | |||||||||||||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 约75% | |||||||||||||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Drug Testing and Analysis顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Identification and analytical characterization of N-propyl norbutylone, N-butyl norbutylone, N-benzyl norheptedrone, and N-pyrrolidinyl-3,4-DMA Author: Liu, Cui-Mei; Hua, Zhen-Dong; Song, Chun-Hui; Jia, Wei Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. 15, Issue 1, pp. 47-57. DOI: 10.1002/dta.3358 PubMed DOI |
2. | Identification of three novel new psychoactive substances 4F-AB-BUTINACA, AB-PHETINACA, and 2F-NENDCK Author: Wang, Kua-Dou; Yuan, Xiao-Liang; Liu, Chen; Cao, Fang-Qi; Zhang, Yu-Rong; Liu, Wen-Bin; He, Si-Yang Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. 15, Issue 1, pp. 115-122. DOI: 10.1002/dta.3359 PubMed DOI |
3. | A multiplex qPCR assay for transgenes detection: A novel approach for gene doping control in horseracing using conventional laboratory setup Author: Wong, Kin-Sing; Cheung, Hiu Wing; Szeto, Cherry W. L.; Tsang, Candice Y. N.; Wan, Terence S. M.; Ho, Emmie N. M. Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/dta.3483 PubMed DOI |
4. | In vitro and in vivo metabolism of 3-Methoxyeticyclidine in human liver microsomes, a zebrafish model, and two human urine samples based on liquid chromatography-high-resolution mass spectrometry Author: Xu, Linhao; Liu, Xinze; Song, Zixuan; Xiang, Ping; Hang, Taijun; Yan, Hui Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/dta.3488 PubMed DOI |
5. | Identification of metabolites of evobrutinib in rat and human hepatocytes by using ultra-high performance liquid chromatography coupled with diode array detector and Q Exactive Orbitrap tandem mass spectrometry. Author: Li Z1, Zhang L1, Yuan Y1, Yang Z1. Journal: Drug Test Anal. 2019 Jan;11(1):129-139. doi: 10.1002/dta.2477. Epub 2018 Aug 29. PubMed DOI |
6. | Metabolism of vesatolimod in rat, dog, and human liver microsomes: Metabolic stability assessment, metabolite identification, and interspecies comparison. Author: Li W1, Zhang J1, Wang Y1, Hu F1, Zhang Y2. Journal: Drug Test Anal. 2019 Feb;11(2):240-249. doi: 10.1002/dta.2483. Epub 2018 Sep 17. PubMed DOI |
7. | Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro. Author: Shen L1, Wang J2, Yi Y1, Ye C1, Wang R3, Xia G1, Yu C1, Tu F1, Xu J1, Zheng Z1. Journal: Drug Test Anal. 2019 Apr;11(4):595-600. doi: 10.1002/dta.2534. Epub 2018 Dec 25. PubMed DOI |
8. | Pharmacokinetics of selegiline, R-methamphetamine, R-amphetamine, and desmethylselegiline in oral fluid after a single oral administration of selegiline. Author: Chen L1,2, Shen B1, Wang S3, Yu Y2, Yan H1, Shi Y1, Duan G2, Xiang P1. Journal: Drug Test Anal. 2019 Jan 6. doi: 10.1002/dta.2568. [Epub ahead of print] PubMed DOI |
9. | Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: A clinical pharmacokinetics and excretion study. Author: Li Y1,2,3, Zhan H1,2,3, Fan Y1,2,3, Zhang J1,2,3, Cao G1,2,3, Yu J1,2,3, Chen Y1,2,3, Guo B1,2,3. Journal: Drug Test Anal. 2019 Feb 28. doi: 10.1002/dta.2579. [Epub ahead of print] PubMed DOI |
10. | LC-MS/MS assay for the determination of a novel anti-fibrotic candidate mefunidone in monkey plasma and its application to a pharmacokinetics study. Author: Han X1, Wen Z1,2, Fan Z3, Ma Y3, Wang L1,4, Cheng Z1. Journal: Drug Test Anal. 2019 Mar 14. doi: 10.1002/dta.2588. [Epub ahead of print] PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室